{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:10:59Z","timestamp":1784956259202,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cancergen.2018.04.002","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T19:08:21Z","timestamp":1523041701000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent"],"prefix":"10.1016","volume":"224-225","author":[{"given":"Z\u00f6e","family":"Powis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6108-7785","authenticated-orcid":false,"given":"Carin R.","family":"Espenschied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"LaDuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-052X","authenticated-orcid":false,"given":"Kelly D.","family":"Hagman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tripti","family":"Paudyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7176-1964","authenticated-orcid":false,"given":"Shuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Knost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2018.04.002_bib0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ana.24251","article-title":"Clinical whole exome sequencing in child neurology practice","volume":"76","author":"Srivastava","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0002","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/gim.2014.58","article-title":"The usefulness of whole-exome sequencing in routine clinical practice","volume":"16","author":"Iglesias","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0003","first-page":"578","article-title":"Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions","volume":"17","author":"Farwell","year":"2015","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0004","article-title":"Clinical application of whole-exome sequencing across clinical indications","author":"Retterer","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","article-title":"Clinical whole-exome sequencing for the diagnosis of mendelian disorders","volume":"369","author":"Yang","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0006","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","author":"Laduca","year":"2014","journal-title":"Genet Med Off J Am Coll Med Gen"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0007","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.1080\/15265161.2016.1150532","article-title":"Response to open peer commentaries on \"ethics consultation quality assessment tool: a novel method for assessing the quality of ethics case consultations based on written records\"","volume":"16","author":"Pearlman","year":"2016","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0008","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0009","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","article-title":"Multigene panel testing detects equal rates of pathogenic BRCA1\/2 mutations and has a higher diagnostic yield compared to limited BRCA1\/2 analysis alone in patients at risk for hereditary breast cancer","volume":"22","author":"Kapoor","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"Minion","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0011","first-page":"9","article-title":"Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing","volume":"18","author":"Christine","year":"2012","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.cancergen.2018.04.002_bib0012","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-12-3863","article-title":"Novel clinically relevant genes in gastrointestinal stromal tumors identified by exome sequencing","volume":"19","author":"Schoppmann","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2016.191","article-title":"Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study","author":"Ghazani","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0014","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2015.5699","article-title":"Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors","author":"Parsons","year":"2016","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.cancergen.2018.04.002_bib0016","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/gim.2016.95","article-title":"Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases","volume":"19","author":"Farwell Hagman","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/humu.23183","article-title":"Classification of genes: standardized clinical validity assessment of gene-disease associations aids diagnostic exome analysis and reclassifications","author":"Smith","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0018","first-page":"405","article-title":"Committee ALQA. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0019","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0021","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199411000-00004","article-title":"Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases","volume":"18","author":"Young","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0022","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.devcel.2010.02.009","article-title":"Tel1\/ETV6 specifies blood stem cells through the agency of VEGF signaling","volume":"18","author":"Ciau-Uitz","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5858\/arpa.2011-0429-CR","article-title":"Burkitt lymphoma arising from lymphoplasmacytic lymphoma following acquisition of MYC translocation and loss of the ETV6 tumor suppressor gene","volume":"137","author":"Peker","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood.V86.1.38.bloodjournal86138","article-title":"Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood","volume":"86","author":"Stegmaier","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0025","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1084\/jem.20112239","article-title":"ETV6 mutations in early immature human T cell leukemias","volume":"208","author":"Van Vlierberghe","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0027","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005262","article-title":"Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia","volume":"11","author":"Topka","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0029","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/138920306778018025","article-title":"Rho GTPase activating proteins in cancer phenotypes","volume":"7","author":"Kandpal","year":"2006","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0031","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.genom.7.080505.115630","article-title":"Predicting the effects of amino acid substitutions on protein function","volume":"7","author":"Ng","year":"2006","journal-title":"Annu Rev Genom Hum Genet"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0032","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1158\/1078-0432.CCR-11-3150","article-title":"Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement","volume":"18","author":"Lok","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2018.04.002_bib0033","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1038\/sj.onc.1202692","article-title":"Mutations in the RAD54 recombination gene in primary cancers","volume":"18","author":"Matsuda","year":"1999","journal-title":"Oncogene"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:42:07Z","timestamp":1761896527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217302624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":33,"alternative-id":["S2210776217302624"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.04.002","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2018.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}